S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NASDAQ:IONS

Ionis Pharmaceuticals (IONS) Earnings Date, Estimates & Call Transcripts

$46.28
+3.62 (+8.49%)
(As of 09/26/2023 ET)
Compare
Today's Range
$43.55
▼
$46.54
50-Day Range
$38.50
▼
$43.64
52-Week Range
$32.69
▼
$47.74
Volume
2.68 million shs
Average Volume
1.04 million shs
Market Capitalization
$6.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$47.80
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Nov. 8Estimated
Actual EPS
(Aug. 9)
$0.60 Beat By $1.54
Consensus EPS
(Aug. 9)
-$0.94
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

IONS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IONS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ionis Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20234($1.27)$1.98($0.22) 
Q2 20235($1.22)($0.86)($1.06) 
Q3 20235($1.18)($0.62)($0.92) 
Q4 20234($1.62)($0.37)($1.01) 
FY 202318($5.29)$0.13($3.19) 
Q1 20242($0.85)($0.72)($0.79) 
Q2 20242($1.04)($1.01)($1.03) 
Q3 20241($0.99)($0.99)($0.99) 
Q4 20241($0.58)($0.58)($0.58) 
FY 20246($3.46)($3.30)($3.38) 
Q1 20251($0.50)($0.50)($0.50) 

IONS Earnings Date and Information

Ionis Pharmaceuticals last released its quarterly earnings data on August 9th, 2023. The reported $0.60 earnings per share for the quarter, topping the consensus estimate of ($0.94) by $1.54. The company had revenue of $188 million for the quarter, compared to analyst estimates of $136.84 million. Ionis Pharmaceuticals has generated ($2.17) earnings per share over the last year (($2.17) diluted earnings per share). Earnings for Ionis Pharmaceuticals are expected to decrease in the coming year, from ($3.35) to ($3.56) per share. Ionis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off prior year's report dates.

Ionis Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/8/2023
Estimated)		------- 
8/9/2023Q2 2023($0.94)$0.60+$1.54$0.60$136.84 million$188.00 million    
5/3/2023Q1 2023($1.00)($0.87)+$0.13($0.87)$126.88 million$131.00 million      
2/22/2023Q4 2022($1.06)($0.37)+$0.69($0.37)$160.21 million$152.00 million      
11/9/2022Q3 2022($0.74)($0.33)+$0.41($0.33)$149.48 million$160.00 million
8/9/2022Q2 2022($0.61)($0.74)($0.13)($0.74)$142.65 million$134.00 million    
5/4/2022Q1 2022($0.68)($0.46)+$0.22($0.46)$122.46 million$142.00 million      
2/24/2022Q4 2021$0.80$1.41+$0.61$1.41$284.08 million$440.00 million    
11/3/2021Q3 2021($0.53)($0.58)($0.05)($0.58)$162.01 million$133.00 million    
8/4/2021Q2 2021($0.56)($0.57)($0.01)($0.57)$128.46 million$126.00 million    
5/5/2021Q1 2021($0.48)($0.64)($0.16)($0.64)$134.93 million$112.00 million    
2/24/2021Q4 2020$0.24($2.44)($2.68)($2.44)$265.93 million$290.00 million    
11/4/2020Q3 2020($0.11)($0.22)($0.11)($0.22)$182.14 million$160.00 million    












Ionis Pharmaceuticals Earnings - Frequently Asked Questions

When is Ionis Pharmaceuticals's earnings date?

Ionis Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off last year's report dates. Learn more on IONS's earnings history.

Did Ionis Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Ionis Pharmaceuticals (NASDAQ:IONS) reported $0.60 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.94) by $1.54. Learn more on analysts' earnings estimate vs. IONS's actual earnings.

How can I listen to Ionis Pharmaceuticals's earnings conference call?

The conference call for Ionis Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Ionis Pharmaceuticals's conference call transcript?

The conference call transcript for Ionis Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Ionis Pharmaceuticals generate each year?

Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded annual revenue of $587 million.

How much profit does Ionis Pharmaceuticals generate each year?

Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded net income of -$269.72 million. IONS has generated -$2.17 earnings per share over the last four quarters.

What is Ionis Pharmaceuticals's EPS forecast for next year?

Ionis Pharmaceuticals's earnings are expected to decrease from ($3.35) per share to ($3.56) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:IONS) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -